Guerbet SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guerbet SA with three other
companies in this sector in France:
sales of 342.61 million Euro [US$373.21 million]
of which 60%
was Operating Segment - Europe),
(607.80 million Euro [US$662.09 million]
of which 51%
was Non-Proprietary Homeopathic Medicines), and
Produits Chimiques Auxiliares et de Synthese
(179.09 million Euro [US$195.08 million]
of which 67%
was Pharmaceutical Synthesis).
During the year ended December of 2015, sales at
Guerbet SA were 488.74 million Euro (US$532.39 million).
increase of 19.5%
versus 2014, when the company's sales were 408.96 million Euro.
Sales of Interventional Radiology and Theranostic saw an increase
that was more than double the company's growth rate: sales were up
42.5% in 2015, from
31.90 million Euro to 45.45 million Euro.
Not all segments of Guerbet SA experienced an increase in sales in 2015:
sales of Other fell 89.2% to 4.40 million Euro.